InvestorsHub Logo
icon url

scouty

05/24/06 9:22 AM

#3832 RE: bocxman #3830

I too have discussed this science with an oncology expert. What's to prevent a "witch hunt" from occuring when a serum positive result is obtained via uptake from an antibody and the afp receptor? This is one issue I meant to discuss with Dr Moro recently--can the blood test determine from what source(cancerous) the sloughed off cells come from? From prostate, breast, etc., or do you then need a tissue sample from a source that needs to be independently verified? Thus, the issue of multiple, hysterical tests and invasive diagnostic procedures.....the recent prostate commentary from the company sounded like a positive statement on the serum test alone being able to differentiate the likely tumor source, which made my contact/dear friend, professor emeritus and all, surmise that, if true, the biocurex blood test along with a psa would be a compelling union of two simple tests...food for thought-perhaps someone on the board can enlighten all on the ability of the serum test to identify cell type.....scouty
icon url

shag

05/25/06 3:03 PM

#3860 RE: bocxman #3830

Bocxman, I'm sure he ment therapeutics when he said it could be
15 years. He didn't say that money couldn't be made in the meantime. He asked me once, if I had made money on that $2.38
spike. I told him no and he didn't have any comment.
As far as his comment on Sloan- Kettering goes,a name was mentioned that I think he knew. I don't even remember the name.
It may have been some one he knew during his training. I don't keep up with such and at the time, didn't know what Sloan-Kettering was. I won't see him again for about 5 months but will pump him for info. then if I can